The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law